Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti–tumor necrosis factor therapy
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
The estimation of a preference-based measure of health from the SF-36
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,026
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Estimation of Average Treatment Effects Based on Propensity Scores
Becker, S. O., & Ichino, A. (2002) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0200200403 · Cited by 2,754
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.
Fries, J. F., Spitz, P. W., & Young, D. Y. (1982) · PubMed · Cited by 1,474
Clarify: Software for Interpreting and Presenting Statistical Results
Tomz, M., Wittenberg, J., & King, G. (2003) · Journal of Statistical Software · doi:10.18637/jss.v008.i01 · Cited by 1,432
The mortality of rheumatoid arthritis
Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., & Cathey, M. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370408 · Cited by 1,310
Self-citationInflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
Cited by
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
“Inflammatory mediators, including TNF, have been implicated in this increased cardiovascular risk, and there is some evidence that anti-TNF therapy ameliorates this risk in patients with rheumatoid arthritis [134].”
BackgroundTumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206624 · Cited by 907
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
McMurray, J. J., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66621-4 · Cited by 831
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
ASAS/EULAR recommendations for the management of ankylosing spondylitis
Zochling, J., van der Heijde, D., Burgos-Vargas, R., Collantes, E., Davis, J. C., Dijkmans, B., Dougados, M., Géher, P., Inman, R. D., Khan, M. A., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041137 · Cited by 702
Innate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Anti-TNF therapy: past, present and future
Monaco, C., Nanchahal, J., Taylor, P., & Feldmann, M. (2015) · International Immunology · doi:10.1093/intimm/dxu102 · Cited by 581
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
Self-citationThe risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years
Nicola, P. J., Maradit‐Kremers, H., Roger, V. L., Jacobsen, S. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20855 · Cited by 483
Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis
Scott, D. L., & Kingsley, G. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmct055183 · Cited by 461
Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 431
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Symmons, D. P. M., & Gabriel, S. E. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.75 · Cited by 406
Comorbidities in rheumatoid arthritis
Michaud, K., & Wolfe, F. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.06.002 · Cited by 400
Self-citationvan Vollenhoven, R. F., Emery, P., Bingham, C. O., Keystone, E. C., Fleischmann, R. M., Furst, D. E., Tyson, N., Collinson, N., & Lehane, P. B. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201956 · Cited by 390
Schiff, M. H., Burmester, G. R., Kent, J. D., Pangan, A. L., Kupper, H., Fitzpatrick, S. B., & Donovan, C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043166 · Cited by 390
Barnabe, C., Martin, B., & Ghali, W. A. (2011) · Arthritis Care & Research · doi:10.1002/acr.20371 · Cited by 368
Using the Propensity Score Method to Estimate Causal Effects: A Review and Practical Guide
Li, M. (2013) · Organizational Research Methods · doi:10.1177/1094428112447816 · Cited by 366
Ledingham, J., Deighton, C., & on behalf of the British Society for Rheumatology Standards, G. A. A. W. G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh464 · Cited by 331
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
Gabriel, S. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.011 · Cited by 315
Cardiovascular morbidity in psoriatic arthritis
Gladman, D. D., Ang, M., Su, L., Tom, B. D. M., Schentag, C. T., & Farewell, V. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094839 · Cited by 304
Hypertension in rheumatoid arthritis
Panoulas, V. F., Metsios, G. S., Pace, A. V., John, H., Treharne, G. J., Banks, M. J., & Kitas, G. D. (2008) · Rheumatology · doi:10.1093/rheumatology/ken159 · Cited by 303
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
van VOLLENHOVEN, R. F., EMERY, P., BINGHAM, C. O., KEYSTONE, E. C., FLEISCHMANN, R., FURST, D. E., MACEY, K., SWEETSER, M., KELMAN, A., & RAO, R. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090856 · Cited by 287
Wolfe, F., Michaud, K., & Pincus, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20549 · Cited by 280
Self-citationGrisar, J., Aletaha, D., Steiner, C. W., Kapral, T., Steiner, S., Seidinger, D., Weigel, G., Schwarzinger, I., Wolozcszuk, W., Steiner, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151875.21836.ae · Cited by 280
Cardiovascular disease in autoimmune rheumatic diseases
Hollan, I., Meroni, P. L., Ahearn, J. M., Cohen Tervaert, J. W., Curran, S., Goodyear, C. S., Hestad, K. A., Kahaleh, B., Riggio, M., Shields, K., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.013 · Cited by 270
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Hansildaar, R., Vedder, D., Baniaamam, M., Tausche, A.-K., Gerritsen, M., & Nurmohamed, M. T. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30221-6 · Cited by 270
Zochling, J., van der Heijde, D., Dougados, M., & Braun, J. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041129 · Cited by 247
TNFα blockade in human diseases: An overview of efficacy and safety
Lin, J., Ziring, D., Desai, S., Kim, S., Wong, M., Korin, Y., Braun, J., Reed, E., Gjertson, D., & Singh, R. R. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.08.012 · Cited by 244
Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population‐based cohort study
Davis, J. M., Maradit Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Therneau, T. M., Roger, V. L., & Gabriel, S. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22418 · Cited by 233
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Semb, A. G., Ikdahl, E., Wibetoe, G., Crowson, C., & Rollefstad, S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0428-y · Cited by 214
Depression and distress predict time to cardiovascular disease in dementia caregivers.
Mausbach, B. T., Patterson, T. L., Rabinowitz, Y. G., Grant, I., & Schulz, R. (2007) · Health Psychology · doi:10.1037/0278-6133.26.5.539 · Cited by 193
“While it is possible this may have affected our results, it is unlikely given that self-report accuracy for heart disease is very high (Bergmann, Byers, Freedman, & Mokdad, 1998), with over 90% accuracy being consistently reported in previous research (Bush, Miller, Golden, & Hale, 1989; Lee et al., 2003; Wolfe & Mich…”
ResultNicola, P. J., Crowson, C. S., Maradit‐Kremers, H., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21560 · Cited by 189
“Although several groups of investigators have reported higher cardiovascular mortality in RA, they did not include or discriminate CHF as a potential contributor (2,3,5–8,43– 46) or only evaluated the risk of death associated with CHF (1), not accounting for the potential contribution of CHF to excess mortality in RA…”
BackgroundMean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy
Gasparyan, A. Y., Sandoo, A., Stavropoulos-Kalinoglou, A., & Kitas, G. D. (2010) · Rheumatology International · doi:10.1007/s00296-009-1345-1 · Cited by 184
“effect of this group of biological agents in RA patients with advanced CVD and moderate to severe heart failure, which are even considered as a contraindication for anti-TNFa therapy [11].”
BackgroundDavis, J. M., Roger, V. L., Crowson, C. S., Kremers, H. M., Therneau, T. M., & Gabriel, S. E. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23798 · Cited by 176
“failure is even greater among patients with RA (2,5,6), in”
Rheumatoid Arthritis A Model of Systemic Inflammation Driving Atherosclerosis
Ku, I. A., Imboden, J. B., Hsue, P. Y., & Ganz, P. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0274 · Cited by 164
AJC Editor's Consensus: Psoriasis and Coronary Artery Disease
Friedewald, V. E., Cather, J. C., Gelfand, J. M., Gordon, K. B., Gibbons, G. H., Grundy, S. M., Jarratt, M. T., Krueger, J. G., Ridker, P. M., Stone, N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.004 · Cited by 163
Metadata
- Authors
- Wolfe, F., & Michaud, K.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 116
- Issue
- 5
- Pages
- 305-311
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1987312456
- Cited by
- 372
- References
- 40
- FWCI
- 21.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.